100%
Highest listed pathwayThree groups reach 100 percent: two flat diagnoses (bulbar palsy and ALS) with no other criteria at all, 8 diagnoses rated 100 percent while documented as currently active (or within a stated duration window), and the top tier of the shared chorea ladder (pronounced, progressive grave type).
What separates the next level: For the active-disease group: once the disease is documented as no longer active, the current text moves to an open minimum-rating floor for residuals, which this hub does not compute. For chorea: the severe tier below describes a less advanced presentation. Every other diagnosis in this range either has its own severity ladder, an active-disease sub-branch, or is disclosure-only.
Review CFR criteria, examples, and evidence
- Official CFR language
- DC 8005 (bulbar palsy) and DC 8017 (amyotrophic lateral sclerosis) each state a flat 100 percent rating. DC 8000 (encephalitis), DC 8002 (malignant brain tumor), DC 8007-8009 (cerebrovascular embolism, thrombosis, or hemorrhage, for 6 months), DC 8011 (poliomyelitis), DC 8012 (hematomyelia, for 6 months), DC 8019 (meningitis), DC 8020 (brain abscess), and DC 8021 (malignant spinal cord tumor) each state 100 percent as active disease, or within their own stated duration window. DC 8105 rates chorea, Sydenham's, pronounced, progressive grave types, at 100 percent -- shared by DC 8106 (Huntington's, direct dispatch) and DC 8107 (acquired athetosis, a judgment-call dispatch).
- Qualification explanation
- A confirmed bulbar palsy or ALS diagnosis alone resolves this tier. The 10 active-disease diagnoses additionally require a confirmed-active (or within-duration) status. The chorea group requires a documented pronounced, progressive grave presentation.
- Examples
- A confirmed diagnosis of ALS.; A confirmed diagnosis of bulbar palsy.; Records documenting active epidemic encephalitis.; Records documenting a malignant brain tumor within the treatment or 2-year continuation period.; Records documenting a pronounced, progressive, grave presentation of Sydenham's or Huntington's chorea.
- Medical evidence
- Neurology or oncology treatment records confirming the diagnosis; Documentation of current disease activity or treatment timeline, where applicable; Documentation of chorea severity, where applicable
- Functional impact examples
- A confirmed diagnosis of bulbar palsy or ALS.; A currently active diagnosis within one of the 10 active-disease categories.; A pronounced, progressive grave chorea presentation.
- Common misconceptions
- ALS's Note directing consideration of special monthly compensation is disclosed only, not a separate computed rating.; A past active-disease diagnosis that has since resolved does not, by itself, establish this tier -- the text requires documented current activity or an applicable duration window.; The text's Note directs consideration of rheumatic etiology and complications for Sydenham's chorea specifically -- disclosed context, not a separate computed rating.
- Related topics
- bulbar palsy; ALS; active disease; residual dispatch; chorea; Sydenham's chorea; Huntington's chorea; athetosis
- Source context
- 38 CFR 4.124a; 8000, 8002, 8005, 8007-8009, 8011, 8012, 8017, 8019-8021, 8105-8107; Current Organic Diseases of the Central Nervous System and Miscellaneous Diseases tables.